BridgeMD
New treatment option for Impacted Mandibular Third Molar
Official title Wound Healing and Bacterial Adherence With Triclosan-Coated Sutures After Mandibular Impacted Third Molar Surgery
ClinicalTrials.gov ID: NCT07386366
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if triclosan-coated absorbable stitches (polyglactin 910 sutures coated with triclosan, an antibacterial agent) help soft tissue heal better and have fewer bacteria stuck to the stitches after lower impacted wisdom tooth surgery in adults aged 18 to 35 years. The main questions it aims to answer are: 1.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18 to 35 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Presence of two symmetric impacted mandibular third molars with the same level of difficulty according to the Pell-Gregory and Winter classification...
- No use of topical or systemic antibiotics for at least 4 weeks before surgery.
- Able and willing to provide written informed consent.
You likely can't join if
- Pregnant or breastfeeding.
- Allergy to local anesthetic (2% lidocaine with 1:100,000 epinephrine) or any medications used in the study.
- Radiographic findings suggestive of a tumor or cyst associated with the impacted mandibular third molar.
- Participant withdraws consent or does not agree to continue participation.
- Unable to attend scheduled follow-up visits.
- Difference in surgical extraction time between the two procedures is 12 minutes or more.
See the full eligibility criteria
- Adults aged 18 to 35 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Presence of two symmetric impacted mandibular third molars with the same level of difficulty according to the Pell-Gregory and Winter classification; the difference in angulation between the two third molars is no more...
- No use of topical or systemic antibiotics for at least 4 weeks before surgery.
- Able and willing to provide written informed consent.
- No active infection associated with the mandibular third molar at the time of enrollment.
- Pregnant or breastfeeding.
- Allergy to local anesthetic (2% lidocaine with 1:100,000 epinephrine) or any medications used in the study.
- Radiographic findings suggestive of a tumor or cyst associated with the impacted mandibular third molar.
- Participant withdraws consent or does not agree to continue participation.
- Unable to attend scheduled follow-up visits.
- Difference in surgical extraction time between the two procedures is 12 minutes or more.
- Suture loss/loosening before completion of the final assessment time point.
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.